Fitch Publishes U.S. CMBS Focus Report on CSMC 2006-C4

NEW YORK--(BUSINESS WIRE)-- Fitch Ratings has published its U.S. CMBS Focus Performance Report on Credit Suisse Commercial Mortgage Trust, series 2006-C4. The report provides a detailed and up-to-date perspective on key credit characteristics of the CSMC 2006-C4 transaction and property-level performance of the related trust loans.

Additional information is available on www.fitchratings.com

Credit Suisse Commercial Mortgage Trust, Series 2006-C4 - U.S. CMBS Focus Performance Report

https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=861315

ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTP://FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEBSITE 'WWW.FITCHRATINGS.COM'. PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE 'CODE OF CONDUCT' SECTION OF THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160128006568/en/

Fitch Ratings
Tiffany Pierce
Associate Director
+1-212-908-9107
Fitch, Inc.
33 Whitehall Street
New York, NY 10004
or
Media Relations
Sandro Scenga, +1 212-908-0278
[email protected]

Source: Fitch Ratings

You May Also Be Interested In

• ZULA NEARS THREE-YEAR MILESTONE AFTER GROWING FROM 140+ GAMES TO 2,800+ TITLES
• Médunik Canada becomes exclusive distributor of INCRELEX® in Canada, strengthening support for children with a rare growth disorder
• Xtract One Technologies Further Expands Into Pharmaceutical and Life Sciences Manufacturing With New Multi-State Deployment